Background The t(14;18)(q32:q21) chromosomal translocation is found in the
majority of nodal follicular lymphomas and in a lower percentage of systemi
c high-grade diffuse large B-cell lymphomas, The translocation results in t
he juxtaposition of the bcl-2 gene on chromosome 18 with the immunoglobulin
heavy chain joining region on chromosome 14. Bcl-2 protein prevents apopto
sis and the translocation leads to overexpression of a functionally normal
Bcl-2 protein that prevents apoptosis of neoplastic cells. Objectives The p
urpose of our study was to analyse cases of primary cutaneous B-cell lympho
ma (PCBCL) for the presence of the t(14;18) translocation and to correlate
the results with Bcl-2 expression and histological subtype.
Methods Forty-four cutaneous B-cell lymphoid proliferations (36 PCBCL, four
follicular B-cell lymphomas with cutaneous presentation and four reactive
B-cell infiltrates) were analysed by polymerase chain reaction amplificatio
n and polyacrylamide gel electrophoresis using consensus primers for the jo
ining region on the immunoglobulin heavy chain gene in combination with eit
her a primer for the major breakpoint region (MBR) or the minor cluster reg
ion (mcr) on chromosome 18.
Results None of 36 PCBCL analysed demonstrated a t(14;18) translocation; ho
wever, three of four systemic follicular B-cell lymphomas presenting in the
skin were found to have a translocation in the MBR, which was confirmed by
sequence analysis. Correlation with Bcl-2 immunostaining showed that of se
ven patients with high-grade cutaneous diffuse large B-cell lymphoma, four
were Bcl-2 positive but had no evidence of a t(14;18) translocation. In the
five cases classified as primary cutaneous follicle centre cell lymphoma,
the neoplastic cells within the germinal centres failed to express Bcl-2. H
owever, Bcl-2-positive neoplastic cells were present in all four cases of s
ystemic follicular lymphoma, including the case that did not show a t(14;18
) translocation. In all cases of marginal zone lymphoma the marginal zone l
ymphocytes were Bcl-2 positive.
Conclusions These findings indicate that the t(14;18) translocation does no
t occur in PCBCL; which suggests the involvement of different pathogenetic
mechanisms compared with their nodal counterparts. Furthermore, the detecti
on of a t(14;18) translocation in cutaneous B-cell lymphoma should suggest
the presence of systemic disease, which underlies the need for exhaustive s
taging procedures.